DorsaVi (ASX:DVL) is switching into high gear
We spoke to DorsaVi’s Group CEO, Mat Regan, about the company’s new research collaboration with ITRI in Taiwan, and how this fits into DVL’s 22 nanometer ReRAM development strategy.
DorsaVi already has a R&D collaboration in place with NTU in Singapore and has recently acquired an extensive neuromorphic processing IP portfolio.
We also spoke about end applications for the technology once commercially available. These include Robotics and Medical applications as well as Autonomous Vehicles, like drones and cars.
Lastly, we discussed one of DVL’s target markets for neuromorphic computing, which is expected to grow very fast in the next 5 to US$20bn in 2030.
Check out the latest research on DVL by Pitt Street Research!
Looking for the Best ASX semiconductor stocks to invest in right now?
